Compare GKOS & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | ASB |
|---|---|---|
| Founded | 1998 | 1861 |
| Country | United States | United States |
| Employees | N/A | 4000 |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | ASB |
|---|---|---|
| Price | $122.45 | $28.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $126.92 | $29.75 |
| AVG Volume (30 Days) | 779.2K | ★ 1.7M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.32 | $21.24 |
| Revenue Next Year | $27.43 | $8.86 |
| P/E Ratio | ★ N/A | $10.23 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $22.48 |
| 52 Week High | $148.11 | $29.52 |
| Indicator | GKOS | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 53.71 |
| Support Level | $79.59 | $27.23 |
| Resistance Level | $123.09 | $28.02 |
| Average True Range (ATR) | 6.56 | 0.54 |
| MACD | -1.43 | -0.07 |
| Stochastic Oscillator | 5.60 | 48.22 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.